Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1lt mice with polygenic obesity

Metabolism: Clinical and Experimental

Volumn 53, Issue 6, 2004, Pages 799-808

  Koza, Robert A ^a   Flurkey, Kevin ^b   Graunke, Dawn M ^b   Braun, Christopher ^b   Pan, Huei Ju ^b   Reifsnyder, Peter C ^b   Kozak, Leslie P ^b   Leiter, Edward H ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR COACTIVATOR 1; PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOSE TISSUE; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; GENE EXPRESSION; GENETIC TRANSCRIPTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARRIER PROTEINS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIOXOLES; EATING; ENERGY METABOLISM; INSULIN; ION CHANNELS; ISLETS OF LANGERHANS; LEPTIN; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THERMOGENESIS; TRANSCRIPTION FACTORS;

EID: 3042732491     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.12.024     Document Type: Article

References (44)

1. Elbein S.C. Perspective The search for genes for type 2 diabetes in the post- genome era. Endocrinology. 143:2002;2012-2018
2. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord. 19:(suppl 1):1995;S52-S59
3. Reifsnyder P.C., Leiter E.H. Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. Diabetes. 51:2002;825-832
4. Reifsnyder P.C., Churchill G., Leiter E.H. Maternal environment and genotype interact to establish diabesity in mice. Genome Res. 10:2000;1568-1578
5. Plum L., Giesen K., Kluge R., et al. Characterisation of the mouse diabetes susceptibilty locus Nidd/SJL Islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Diabetologia. 45:2002;823-830
6. Taylor B.A., Wnek C., Schroeder D., et al. Multiple obesity QTLs identified in an intercross between the NZO (New Zealand Obese) and the SM (small) mouse strains. Mamm Genome. 12:2001;95-103
7. Igel M., Becker W., Herberg L., et al. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Endocrinology. 138:1997;4234-4239
8. Halaas J.L., Boozer C., Denton D.A., et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA. 94:1997;8878-8883
9. Hileman S.M., Pierroz D.D., Masuzaki H., et al. Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology. 143:2002;775-783
10. Veroni M., Proietto J., Larkins R. Evolution of insulin resistance in New Zealand Obese mice. Diabetes. 40:1991;1480-1487
11. Andrikopoulos S., Rosella G., Kaczmarczyk S.J., et al. Impaired regulation of hepatic fructose-1, 6-bisphosphatase in the New Zealand Obese mouse An acquired defect. Metabolism. 45:1996;622-626
12. Flurkey K., Rosen C., Partke H.-J., et al. Rapid maturational growth as a predictor of NIDDM in NZO male mice. Diabetes. 47:(suppl 1):1998;A318. abstr
13. Collins S., Daniel K.W., Rohlfs E.M. Depressed expression of adipocyte beta-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents. Int J Obes Relat Metab Disord. 23:1999;669-677
14. Himms-Hagen J., Cui J., Danforth E. Jr, et al. Effect of CL-316, 243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol. 266:1994;R1371-1382
15. Watkins S.M., Reifsnyder P.C., Pan H.-J., et al. Lipid metabolome-wide effects of the peroxisome proliferator-activated receptor gamma agonist rosiglitazone on a new mouse model of type 2 diabetes. J Lipid Res. 43:2002;1809-1817
16. Koza R.A., Hohmann S.M., Guerra C., et al. Synergistic gene interactions control the induction of the mitochondrial uncoupling protein (Ucp1) gene in white fat tissue. J Biol Chem. 275:2000;34486-34492
17. Collins S., Daniel K.W., Petro A.E., et al. Strain-specific response (suppl) to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology. 138:1997;405-413
18. Ridgway N.D., Vance D.E. Purification of phosphatidylethanolamine N-methyltransferase from rat liver. J Biol Chem. 262:1987;17231-17239
19. Kodaki T., Yamashita S. Yeast phosphatidylethanolamine methylation pathway. Cloning and characterization of two distinct methyltransferase genes. J Biol Chem. 262:1987;15428-15435
20. Cui Z., Vance J.E., Chen M.H., et al. Cloning and expression of a novel phosphatidylethanolamine N-methyltransferase. A specific biochemical and cytological marker for a unique membrane fraction in rat liver. J Biol Chem. 268:1993;16655-16663
21. Yoshida T., Sakane N., Wakabayashi Y., et al. Anti-obesity and anti-diabetic effects of CL 316, 243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice. Life Sci. 54:1994;491-498
22. Umekawa T., Yoshida T., Sakane N., et al. Anti-obesity and anti-diabetic effects of CL316, 243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats Induction of uncoupling protein and activation of glucose transporter 4 in white fat. Eur J Endocrinol. 136:1997;429-437
23. Liu X., Perusse F., Bukowiecki L.J. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Am J Physiol. 274:1998;R1212-R1219
24. Tsujii S., Bray G.A. A beta-3 adrenergic agonist (BRL-37, 344) decreases food intake. Physiol Behav. 63:1998;723-728
25. Haskell B.D., Flurkey K., Duffy T.M., et al. The diabetes-prone NZO/HlLt Strain. I. Immunophenotypic comparison to the related NZB/BinJ and NZW/LacJ strains. Lab Invest. 82:2002;833-842
26. Junger E., Herberg L., Jeruschke K., et al. The diabetes-prone NZO/Hl strain: II. Pancreatic immunopathology. Lab Invest. 82:2002;843-853
27. Guerra C., Koza R.A., Yamashita H., et al. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest. 102:1998;412-420
28. Surwit R.S., Dixon T.M., Petro A.E., et al. Diazoxide restores b3-adrenergic receptor funtion in diet-induced obesity and diabetes. Endocrinology. 141:2000;3630-3637
29. Yoshida T., Sakane N., Wakabayashi Y., et al. Anti-obesity effect of CL 316, 243, a highly specific beta 3-adrenoceptor agonist, in mice with monosodium-L-glutamate-induced obesity. Eur J Endocrinol. 131:1994;97-102
30. Griffiths A.J., Humphreys S.M., Clark M.L., et al. Immediate metabolic availability of dietary fat in combination with carbohydrate. Am J Clin Nutr. 59:1994;53-59
31. Flatt J.P., Ravussin E., Acheson K.J., et al. Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J Clin Invest. 76:1985;1019-1024
32. Flatt J.P. Body composition, respiratory quotient, and weight maintenance. Am J Clin Nutr. 62:(suppl):1995;1107S-1117S
33. Cianflone K. Acylation stimulating protein and the adipocyte. J Endocrinol. 155:1997;203-206
34. Cianflone K., Xia Z., Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta. 1609:2003;127-143
35. Yu S., Matsusue K., Kashireddy P., et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem. 278:2003;498-505
36. Gregoire F.M., Zhang Q., Smith S.J., et al. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab. 282:2002;E703-E713
37. Gong D.W., He Y., Karas M., et al. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem. 272:1997;24129-24132
38. Weigle D.S., Selfridge L.E., Schwartz M.W., et al. Elevated free fatty acids induce uncoupling protein 3 expression in muscle A potential explanation for the effect of fasting. Diabetes. 47:1998;298-302
39. Nakamura Y., Nagase I., Asano A., et al. Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse. J Vet Med Sci. 63:2001;309-314
40. Yoshitomi H., Yamazaki K., Abe S., et al. Differential regulation of mouse uncoupling proteins among brown adipose tissue, white adipose tissue, and skeletal muscle in chronic beta 3 adrenergic receptor agonist treatment. Biochem Biophys Res Commun. 253:1998;85-91
41. Eriksson K.F., Lindgarde F. Impaired glucose tolerance in a middle-aged male urban population. Diabetologia. 45:1990;526-531
42. Mootha V.K., Lindgren C.M., Eriksson K.-F., et al. PGC-1α- responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 34:2003;267-273
43. Lin J., Wu H., Tarr P.T., et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscles fibres. Nature. 418:2002;797-801
44. Grujic D., Susulic V.S., Harper M.E., et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem. 272:1997;17686-17693